Kite Pharma

Oxford BioTherapeutics to research cell therapies for Gilead’s Kite

https://pharmaphorum.com/news/oxford-biotherapeutics-to-research-cell-therapies-for-gileads-kite/

Kite cues up first EMA okay for mantle cell lymphoma CAR-T

https://pharmaphorum.com/news/kite-cues-up-first-ema-okay-for-mantle-cell-lymphoma-car-t/

Gilead’s Kite gains some height after second CAR-T approval in US

https://pharmaphorum.com/news/gileads-kite-gains-some-height-after-second-car-t-approval-in-us/

Gilead closes in on second CAR-T approval in US

https://pharmaphorum.com/news/gilead-closes-in-on-second-car-t-approval-in-us/

EMA starts review of second CAR-T from Gilead’s Kite unit

https://pharmaphorum.com/news/ema-starts-review-of-second-car-t-from-gileads-kite-unit/

Ex-Kite chiefs’ biotech to research ‘off-the-shelf’ CAR-Ts with Cellectis

https://pharmaphorum.com/news/ex-kite-chiefs-biotech-research-off-shelf-car-ts-cellectis/

Gilead completes $11.9bn Kite acquisition

https://pharmaphorum.com/news/gilead-kite-acquisition/

Novartis’ CAR-T drug needs new payment model, says Express Scripts

https://pharmaphorum.com/news/novartis-car-t-expensive-us-health-system-express-scripts/

Gilead swoops to buy Kite for $12billion

https://pharmaphorum.com/news/gilead-swoops-buy-kite-12billion/

1 2 3

Close in 10 seconds

Pharmaphorum.com

Search